EMEA-000637-PIP01-09-M01
Key facts
| Invented name |
Fosrenol and associated name Foznol
|
| Active substance |
Lanthanum carbonate hydrate
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/22/2010
|
| PIP number |
EMEA-000637-PIP01-09-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Hyperphosphataemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Shire Pharmaceutical Contracts Ltd
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|